#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1. Introduction
1-1	0-2	1.	_	_	_	_
1-2	3-15	Introduction	abstract	new	_	_

#Text=The development of nanostructures that mimic the remarkable functions and catalytic properties of natural enzymes , i.e. , to create nanozymes , has been an exciting topic in the field of nanotechnology for the last two decades .
2-1	16-19	The	abstract[2]	new[2]	coref	2-25[8_2]
2-2	20-31	development	abstract[2]	new[2]	_	_
2-3	32-34	of	abstract[2]	new[2]	_	_
2-4	35-49	nanostructures	abstract[2]|object[3]	new[2]|new[3]	_	_
2-5	50-54	that	abstract[2]|object[3]	new[2]|new[3]	_	_
2-6	55-60	mimic	abstract[2]|object[3]	new[2]|new[3]	_	_
2-7	61-64	the	abstract[2]|object[3]|abstract[4]	new[2]|new[3]|new[4]	_	_
2-8	65-75	remarkable	abstract[2]|object[3]|abstract[4]	new[2]|new[3]|new[4]	_	_
2-9	76-85	functions	abstract[2]|object[3]|abstract[4]	new[2]|new[3]|new[4]	_	_
2-10	86-89	and	abstract[2]|object[3]	new[2]|new[3]	_	_
2-11	90-99	catalytic	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-12	100-110	properties	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-13	111-113	of	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-14	114-121	natural	abstract[2]|object[3]|abstract[5]|substance[6]	new[2]|new[3]|new[5]|new[6]	_	_
2-15	122-129	enzymes	abstract[2]|object[3]|abstract[5]|substance[6]	new[2]|new[3]|new[5]|new[6]	_	_
2-16	130-131	,	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-17	132-136	i.e.	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-18	137-138	,	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-19	139-141	to	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-20	142-148	create	abstract[2]|object[3]|abstract[5]	new[2]|new[3]|new[5]	_	_
2-21	149-158	nanozymes	abstract[2]|object[3]|abstract[5]|object	new[2]|new[3]|new[5]|new	coref	3-7
2-22	159-160	,	_	_	_	_
2-23	161-164	has	_	_	_	_
2-24	165-169	been	_	_	_	_
2-25	170-172	an	abstract[8]	giv[8]	_	_
2-26	173-181	exciting	abstract[8]	giv[8]	_	_
2-27	182-187	topic	abstract[8]	giv[8]	_	_
2-28	188-190	in	abstract[8]	giv[8]	_	_
2-29	191-194	the	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-30	195-200	field	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-31	201-203	of	abstract[8]|abstract[9]	giv[8]|new[9]	_	_
2-32	204-218	nanotechnology	abstract[8]|abstract[9]|abstract	giv[8]|new[9]|new	_	_
2-33	219-222	for	abstract[8]	giv[8]	_	_
2-34	223-226	the	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-35	227-231	last	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-36	232-235	two	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-37	236-243	decades	abstract[8]|time[11]	giv[8]|new[11]	_	_
2-38	244-245	.	_	_	_	_

#Text=Among several approaches used to create nanozymes , the self-assembly of thiolated ligands onto the surface of gold nanoparticles ( Au-NPs ) to obtain monolayer-protected gold clusters ( Au-MPCs ) has emerged as a powerful strategy .
3-1	246-251	Among	_	_	_	_
3-2	252-259	several	abstract[12]	new[12]	coref	15-23[150_12]
3-3	260-270	approaches	abstract[12]	new[12]	_	_
3-4	271-275	used	abstract[12]	new[12]	_	_
3-5	276-278	to	abstract[12]	new[12]	_	_
3-6	279-285	create	abstract[12]	new[12]	_	_
3-7	286-295	nanozymes	abstract[12]|object	new[12]|giv	_	_
3-8	296-297	,	_	_	_	_
3-9	298-301	the	organization[14]	new[14]	_	_
3-10	302-315	self-assembly	organization[14]	new[14]	_	_
3-11	316-318	of	organization[14]	new[14]	_	_
3-12	319-328	thiolated	organization[14]|substance[15]	new[14]|new[15]	_	_
3-13	329-336	ligands	organization[14]|substance[15]	new[14]|new[15]	_	_
3-14	337-341	onto	organization[14]|substance[15]	new[14]|new[15]	_	_
3-15	342-345	the	organization[14]|substance[15]|place[16]	new[14]|new[15]|new[16]	coref	4-10[26_16]
3-16	346-353	surface	organization[14]|substance[15]|place[16]	new[14]|new[15]|new[16]	_	_
3-17	354-356	of	organization[14]|substance[15]|place[16]	new[14]|new[15]|new[16]	_	_
3-18	357-361	gold	organization[14]|substance[15]|place[16]|substance|object[18]	new[14]|new[15]|new[16]|new|new[18]	coref|coref	3-26|4-13[28_18]
3-19	362-375	nanoparticles	organization[14]|substance[15]|place[16]|object[18]	new[14]|new[15]|new[16]|new[18]	_	_
3-20	376-377	(	organization[14]	new[14]	_	_
3-21	378-384	Au-NPs	organization[14]|abstract	new[14]|new	coref	6-6
3-22	385-386	)	organization[14]	new[14]	_	_
3-23	387-389	to	organization[14]	new[14]	_	_
3-24	390-396	obtain	organization[14]	new[14]	_	_
3-25	397-416	monolayer-protected	organization[14]|object[21]	new[14]|new[21]	_	_
3-26	417-421	gold	organization[14]|substance|object[21]	new[14]|giv|new[21]	coref	4-13
3-27	422-430	clusters	organization[14]|object[21]	new[14]|new[21]	_	_
3-28	431-432	(	_	_	_	_
3-29	433-440	Au-MPCs	abstract	new	_	_
3-30	441-442	)	_	_	_	_
3-31	443-446	has	_	_	_	_
3-32	447-454	emerged	_	_	_	_
3-33	455-457	as	_	_	_	_
3-34	458-459	a	abstract[23]	new[23]	_	_
3-35	460-468	powerful	abstract[23]	new[23]	_	_
3-36	469-477	strategy	abstract[23]	new[23]	_	_
3-37	478-479	.	_	_	_	_

#Text=In particular , the conjugation of peptides on to the surface of gold nanoparticles to yield peptide – gold nanoparticle conjugates ( Pep-Au-NPs ) expanded the possibilities for the design of artificial enzymes .
4-1	480-482	In	_	_	_	_
4-2	483-493	particular	_	_	_	_
4-3	494-495	,	_	_	_	_
4-4	496-499	the	event[24]	new[24]	_	_
4-5	500-511	conjugation	event[24]	new[24]	_	_
4-6	512-514	of	event[24]	new[24]	_	_
4-7	515-523	peptides	event[24]|substance	new[24]|new	coref	5-1
4-8	524-526	on	event[24]	new[24]	_	_
4-9	527-529	to	event[24]	new[24]	_	_
4-10	530-533	the	event[24]|place[26]	new[24]|giv[26]	_	_
4-11	534-541	surface	event[24]|place[26]	new[24]|giv[26]	_	_
4-12	542-544	of	event[24]|place[26]	new[24]|giv[26]	_	_
4-13	545-549	gold	event[24]|place[26]|substance|object[28]	new[24]|giv[26]|giv|giv[28]	coref	4-19
4-14	550-563	nanoparticles	event[24]|place[26]|object[28]	new[24]|giv[26]|giv[28]	_	_
4-15	564-566	to	event[24]	new[24]	_	_
4-16	567-572	yield	event[24]	new[24]	_	_
4-17	573-580	peptide	event[24]|substance[29]|abstract[32]	new[24]|new[29]|new[32]	appos|coref	4-23[0_32]|5-9[0_29]
4-18	581-582	–	event[24]|substance[29]|abstract[32]	new[24]|new[29]|new[32]	_	_
4-19	583-587	gold	event[24]|substance[29]|substance|abstract[32]	new[24]|new[29]|giv|new[32]	_	_
4-20	588-600	nanoparticle	event[24]|abstract|abstract[32]	new[24]|new|new[32]	_	_
4-21	601-611	conjugates	event[24]|abstract[32]	new[24]|new[32]	_	_
4-22	612-613	(	_	_	_	_
4-23	614-624	Pep-Au-NPs	abstract	giv	coref	9-9
4-24	625-626	)	_	_	_	_
4-25	627-635	expanded	_	_	_	_
4-26	636-639	the	abstract[34]	new[34]	_	_
4-27	640-653	possibilities	abstract[34]	new[34]	_	_
4-28	654-657	for	abstract[34]	new[34]	_	_
4-29	658-661	the	abstract[34]|abstract[35]	new[34]|new[35]	coref	5-13[42_35]
4-30	662-668	design	abstract[34]|abstract[35]	new[34]|new[35]	_	_
4-31	669-671	of	abstract[34]|abstract[35]	new[34]|new[35]	_	_
4-32	672-682	artificial	abstract[34]|abstract[35]|abstract[36]	new[34]|new[35]|new[36]	ana	5-13[0_36]
4-33	683-690	enzymes	abstract[34]|abstract[35]|abstract[36]	new[34]|new[35]|new[36]	_	_
4-34	691-692	.	_	_	_	_

#Text=Peptides are available at low cost by solid-phase peptide synthesis , and their modular design paired with the available repertoire of natural and non-natural amino acids allows for facile diversification of functional groups , and thus the resulting catalytic activities and substrate specificities of the peptide shell .
5-1	693-701	Peptides	substance	giv	coref	6-4
5-2	702-705	are	_	_	_	_
5-3	706-715	available	_	_	_	_
5-4	716-718	at	_	_	_	_
5-5	719-722	low	abstract[38]	new[38]	_	_
5-6	723-727	cost	abstract[38]	new[38]	_	_
5-7	728-730	by	_	_	_	_
5-8	731-742	solid-phase	event[40]	new[40]	coref	16-31[162_40]
5-9	743-750	peptide	substance|event[40]	giv|new[40]	coref	5-46
5-10	751-760	synthesis	event[40]	new[40]	_	_
5-11	761-762	,	_	_	_	_
5-12	763-766	and	_	_	_	_
5-13	767-772	their	abstract|abstract[42]	giv|giv[42]	coref	9-4[78_42]
5-14	773-780	modular	abstract[42]	giv[42]	_	_
5-15	781-787	design	abstract[42]	giv[42]	_	_
5-16	788-794	paired	abstract[42]	giv[42]	_	_
5-17	795-799	with	abstract[42]	giv[42]	_	_
5-18	800-803	the	abstract[42]|abstract[43]	giv[42]|new[43]	_	_
5-19	804-813	available	abstract[42]|abstract[43]	giv[42]|new[43]	_	_
5-20	814-824	repertoire	abstract[42]|abstract[43]	giv[42]|new[43]	_	_
5-21	825-827	of	abstract[42]|abstract[43]	giv[42]|new[43]	_	_
5-22	828-835	natural	abstract[42]|abstract[43]|substance[45]	giv[42]|new[43]|new[45]	_	_
5-23	836-839	and	abstract[42]|abstract[43]|substance[45]	giv[42]|new[43]|new[45]	_	_
5-24	840-851	non-natural	abstract[42]|abstract[43]|substance[45]	giv[42]|new[43]|new[45]	_	_
5-25	852-857	amino	abstract[42]|abstract[43]|object|substance[45]	giv[42]|new[43]|new|new[45]	_	_
5-26	858-863	acids	abstract[42]|abstract[43]|substance[45]	giv[42]|new[43]|new[45]	_	_
5-27	864-870	allows	_	_	_	_
5-28	871-874	for	_	_	_	_
5-29	875-881	facile	abstract[46]	new[46]	_	_
5-30	882-897	diversification	abstract[46]	new[46]	_	_
5-31	898-900	of	abstract[46]	new[46]	_	_
5-32	901-911	functional	abstract[46]|abstract[47]	new[46]|new[47]	coref	7-15[69_47]
5-33	912-918	groups	abstract[46]|abstract[47]	new[46]|new[47]	_	_
5-34	919-920	,	_	_	_	_
5-35	921-924	and	_	_	_	_
5-36	925-929	thus	abstract[48]	new[48]	_	_
5-37	930-933	the	abstract[48]	new[48]	_	_
5-38	934-943	resulting	abstract[48]	new[48]	_	_
5-39	944-953	catalytic	abstract[48]	new[48]	_	_
5-40	954-964	activities	abstract[48]	new[48]	_	_
5-41	965-968	and	_	_	_	_
5-42	969-978	substrate	person|abstract[50]	new|new[50]	coref	7-20
5-43	979-992	specificities	abstract[50]	new[50]	_	_
5-44	993-995	of	abstract[50]	new[50]	_	_
5-45	996-999	the	abstract[50]|object[52]	new[50]|new[52]	_	_
5-46	1000-1007	peptide	abstract[50]|substance|object[52]	new[50]|giv|new[52]	coref	6-10
5-47	1008-1013	shell	abstract[50]|object[52]	new[50]|new[52]	_	_
5-48	1014-1015	.	_	_	_	_

#Text=The conjunction of peptides and Au-NPs leads to dense peptide monolayers in which new hydrogen bond and/or charge interactions between individual peptides are established .
6-1	1016-1019	The	abstract[53]	new[53]	_	_
6-2	1020-1031	conjunction	abstract[53]	new[53]	_	_
6-3	1032-1034	of	abstract[53]	new[53]	_	_
6-4	1035-1043	peptides	abstract[53]|substance|substance[55]	new[53]|giv|giv[55]	coref|coref	6-4[55_0]|6-21[63_55]
6-5	1044-1047	and	abstract[53]|substance[55]	new[53]|giv[55]	_	_
6-6	1048-1054	Au-NPs	abstract[53]|substance[55]|abstract	new[53]|giv[55]|giv	_	_
6-7	1055-1060	leads	_	_	_	_
6-8	1061-1063	to	_	_	_	_
6-9	1064-1069	dense	object[58]	new[58]	_	_
6-10	1070-1077	peptide	substance|object[58]	giv|new[58]	coref	8-15[76_0]
6-11	1078-1088	monolayers	object[58]	new[58]	_	_
6-12	1089-1091	in	object[58]	new[58]	_	_
6-13	1092-1097	which	object[58]	new[58]	_	_
6-14	1098-1101	new	object[58]|abstract[60]	new[58]|new[60]	ana	7-1[0_60]
6-15	1102-1110	hydrogen	object[58]|substance|abstract[60]	new[58]|new|new[60]	coref	11-25
6-16	1111-1115	bond	object[58]|abstract[60]	new[58]|new[60]	_	_
6-17	1116-1122	and/or	object[58]	new[58]	_	_
6-18	1123-1129	charge	object[58]|abstract|abstract[62]	new[58]|new|new[62]	_	_
6-19	1130-1142	interactions	object[58]|abstract[62]	new[58]|new[62]	_	_
6-20	1143-1150	between	object[58]|abstract[62]	new[58]|new[62]	_	_
6-21	1151-1161	individual	object[58]|abstract[62]|substance[63]	new[58]|new[62]|giv[63]	_	_
6-22	1162-1170	peptides	object[58]|abstract[62]|substance[63]	new[58]|new[62]|giv[63]	_	_
6-23	1171-1174	are	object[58]	new[58]	_	_
6-24	1175-1186	established	object[58]	new[58]	_	_
6-25	1187-1188	.	_	_	_	_

#Text=This enables known enzyme-like effects , such as the perturbation of pKa values of functional groups and cooperativity in substrate binding , and can even lead to new catalytic mechanisms .
7-1	1189-1193	This	abstract	giv	_	_
7-2	1194-1201	enables	_	_	_	_
7-3	1202-1207	known	abstract[65]	new[65]	coref	8-3[74_65]
7-4	1208-1219	enzyme-like	abstract[65]	new[65]	_	_
7-5	1220-1227	effects	abstract[65]	new[65]	_	_
7-6	1228-1229	,	abstract[65]	new[65]	_	_
7-7	1230-1234	such	abstract[65]	new[65]	_	_
7-8	1235-1237	as	abstract[65]	new[65]	_	_
7-9	1238-1241	the	abstract[65]|abstract[66]	new[65]|new[66]	_	_
7-10	1242-1254	perturbation	abstract[65]|abstract[66]	new[65]|new[66]	_	_
7-11	1255-1257	of	abstract[65]|abstract[66]	new[65]|new[66]	_	_
7-12	1258-1261	pKa	abstract[65]|abstract[66]|abstract|abstract[68]	new[65]|new[66]|new|new[68]	coref	13-4[124_0]
7-13	1262-1268	values	abstract[65]|abstract[66]|abstract[68]	new[65]|new[66]|new[68]	_	_
7-14	1269-1271	of	abstract[65]|abstract[66]|abstract[68]	new[65]|new[66]|new[68]	_	_
7-15	1272-1282	functional	abstract[65]|abstract[66]|abstract[68]|abstract[69]	new[65]|new[66]|new[68]|giv[69]	_	_
7-16	1283-1289	groups	abstract[65]|abstract[66]|abstract[68]|abstract[69]	new[65]|new[66]|new[68]|giv[69]	_	_
7-17	1290-1293	and	abstract[65]|abstract[66]	new[65]|new[66]	_	_
7-18	1294-1307	cooperativity	abstract[65]|abstract[66]|abstract[70]	new[65]|new[66]|new[70]	_	_
7-19	1308-1310	in	abstract[65]|abstract[66]|abstract[70]	new[65]|new[66]|new[70]	_	_
7-20	1311-1320	substrate	abstract[65]|abstract[66]|abstract[70]|person|abstract[72]	new[65]|new[66]|new[70]|giv|new[72]	_	_
7-21	1321-1328	binding	abstract[65]|abstract[66]|abstract[70]|abstract[72]	new[65]|new[66]|new[70]|new[72]	_	_
7-22	1329-1330	,	_	_	_	_
7-23	1331-1334	and	_	_	_	_
7-24	1335-1338	can	_	_	_	_
7-25	1339-1343	even	_	_	_	_
7-26	1344-1348	lead	_	_	_	_
7-27	1349-1351	to	_	_	_	_
7-28	1352-1355	new	abstract[73]	new[73]	_	_
7-29	1356-1365	catalytic	abstract[73]	new[73]	_	_
7-30	1366-1376	mechanisms	abstract[73]	new[73]	_	_
7-31	1377-1378	.	_	_	_	_

#Text=Altogether , these effects can greatly improve the catalytic performance of a conjugated versus an unconjugated peptide .
8-1	1379-1389	Altogether	_	_	_	_
8-2	1390-1391	,	_	_	_	_
8-3	1392-1397	these	abstract[74]	giv[74]	_	_
8-4	1398-1405	effects	abstract[74]	giv[74]	_	_
8-5	1406-1409	can	_	_	_	_
8-6	1410-1417	greatly	_	_	_	_
8-7	1418-1425	improve	_	_	_	_
8-8	1426-1429	the	abstract[75]	new[75]	_	_
8-9	1430-1439	catalytic	abstract[75]	new[75]	_	_
8-10	1440-1451	performance	abstract[75]	new[75]	_	_
8-11	1452-1454	of	abstract[75]	new[75]	_	_
8-12	1455-1456	a	abstract[75]	new[75]	_	_
8-13	1457-1467	conjugated	abstract[75]	new[75]	_	_
8-14	1468-1474	versus	abstract[75]	new[75]	_	_
8-15	1475-1477	an	abstract[75]|substance[76]	new[75]|giv[76]	_	_
8-16	1478-1490	unconjugated	abstract[75]|substance[76]	new[75]|giv[76]	_	_
8-17	1491-1498	peptide	abstract[75]|substance[76]	new[75]|giv[76]	_	_
8-18	1499-1500	.	_	_	_	_

#Text=To date , the design and application of Pep-Au-NPs have been limited to organic esterase chemistry , in which catalysis is mediated by a His-imidazole .
9-1	1501-1503	To	_	_	_	_
9-2	1504-1508	date	time	new	_	_
9-3	1509-1510	,	_	_	_	_
9-4	1511-1514	the	abstract[78]|abstract[79]	giv[78]|new[79]	coref	16-28[161_79]
9-5	1515-1521	design	abstract[78]|abstract[79]	giv[78]|new[79]	_	_
9-6	1522-1525	and	abstract[79]	new[79]	_	_
9-7	1526-1537	application	abstract[79]|abstract[80]	new[79]|new[80]	coref	15-1[143_80]
9-8	1538-1540	of	abstract[79]|abstract[80]	new[79]|new[80]	_	_
9-9	1541-1551	Pep-Au-NPs	abstract[79]|abstract[80]|abstract	new[79]|new[80]|giv	coref	16-12
9-10	1552-1556	have	_	_	_	_
9-11	1557-1561	been	_	_	_	_
9-12	1562-1569	limited	_	_	_	_
9-13	1570-1572	to	_	_	_	_
9-14	1573-1580	organic	abstract[83]	new[83]	_	_
9-15	1581-1589	esterase	substance|abstract[83]	new|new[83]	_	_
9-16	1590-1599	chemistry	abstract[83]	new[83]	_	_
9-17	1600-1601	,	abstract[83]	new[83]	_	_
9-18	1602-1604	in	abstract[83]	new[83]	_	_
9-19	1605-1610	which	abstract[83]	new[83]	_	_
9-20	1611-1620	catalysis	abstract[83]|abstract	new[83]|new	_	_
9-21	1621-1623	is	abstract[83]	new[83]	_	_
9-22	1624-1632	mediated	abstract[83]	new[83]	_	_
9-23	1633-1635	by	abstract[83]	new[83]	_	_
9-24	1636-1637	a	abstract[83]|substance[85]	new[83]|new[85]	_	_
9-25	1638-1651	His-imidazole	abstract[83]|substance[85]	new[83]|new[85]	_	_
9-26	1652-1653	.	_	_	_	_

#Text=Considering the fact that zinc metalloenzymes perform numerous other types of reactions in nature , including phosphodiester and amide hydrolysis as well as the ( de)hydrogenation of alcohols , it is of great interest to reconstitute such transformations in vitro by developing appropriate robust synthetic systems .
10-1	1654-1665	Considering	_	_	_	_
10-2	1666-1669	the	abstract[86]	new[86]	ana	10-30[0_86]
10-3	1670-1674	fact	abstract[86]	new[86]	_	_
10-4	1675-1679	that	abstract[86]	new[86]	_	_
10-5	1680-1684	zinc	abstract[86]|substance|substance[88]	new[86]|new|new[88]	coref	11-13
10-6	1685-1699	metalloenzymes	abstract[86]|substance[88]	new[86]|new[88]	_	_
10-7	1700-1707	perform	abstract[86]	new[86]	_	_
10-8	1708-1716	numerous	abstract[86]|place[89]	new[86]|new[89]	_	_
10-9	1717-1722	other	abstract[86]|place[89]	new[86]|new[89]	_	_
10-10	1723-1728	types	abstract[86]|place[89]	new[86]|new[89]	_	_
10-11	1729-1731	of	abstract[86]|place[89]	new[86]|new[89]	_	_
10-12	1732-1741	reactions	abstract[86]|place[89]|event	new[86]|new[89]|new	_	_
10-13	1742-1744	in	abstract[86]	new[86]	_	_
10-14	1745-1751	nature	abstract[86]|abstract	new[86]|new	_	_
10-15	1752-1753	,	abstract[86]	new[86]	_	_
10-16	1754-1763	including	abstract[86]	new[86]	_	_
10-17	1764-1778	phosphodiester	abstract[86]|substance|abstract[94]	new[86]|new|new[94]	_	_
10-18	1779-1782	and	abstract[86]|abstract[94]	new[86]|new[94]	_	_
10-19	1783-1788	amide	abstract[86]|substance|abstract[94]	new[86]|new|new[94]	_	_
10-20	1789-1799	hydrolysis	abstract[86]|abstract[94]	new[86]|new[94]	_	_
10-21	1800-1802	as	abstract[86]	new[86]	_	_
10-22	1803-1807	well	abstract[86]	new[86]	_	_
10-23	1808-1810	as	abstract[86]	new[86]	_	_
10-24	1811-1814	the	abstract[86]	new[86]	_	_
10-25	1815-1816	(	abstract[86]	new[86]	_	_
10-26	1817-1833	de)hydrogenation	abstract[86]	new[86]	_	_
10-27	1834-1836	of	abstract[86]	new[86]	_	_
10-28	1837-1845	alcohols	abstract[86]|substance	new[86]|new	_	_
10-29	1846-1847	,	_	_	_	_
10-30	1848-1850	it	abstract	giv	_	_
10-31	1851-1853	is	_	_	_	_
10-32	1854-1856	of	_	_	_	_
10-33	1857-1862	great	_	_	_	_
10-34	1863-1871	interest	_	_	_	_
10-35	1872-1874	to	_	_	_	_
10-36	1875-1887	reconstitute	_	_	_	_
10-37	1888-1892	such	abstract[97]	new[97]	_	_
10-38	1893-1908	transformations	abstract[97]	new[97]	_	_
10-39	1909-1911	in	_	_	_	_
10-40	1912-1917	vitro	organization	new	_	_
10-41	1918-1920	by	_	_	_	_
10-42	1921-1931	developing	_	_	_	_
10-43	1932-1943	appropriate	abstract[99]	new[99]	coref	14-26[142_99]
10-44	1944-1950	robust	abstract[99]	new[99]	_	_
10-45	1951-1960	synthetic	abstract[99]	new[99]	_	_
10-46	1961-1968	systems	abstract[99]	new[99]	_	_
10-47	1969-1970	.	_	_	_	_

#Text=For example , carbonic anhydrase ( CA ) is a naturally occurring zinc metalloenzyme that efficiently and reversibly catalyzes the hydration of CO2 into hydrogen carbonate ( HCO3− ) .
11-1	1971-1974	For	_	_	_	_
11-2	1975-1982	example	_	_	_	_
11-3	1983-1984	,	_	_	_	_
11-4	1985-1993	carbonic	abstract|substance[101]	new|new[101]	coref	11-10[104_101]
11-5	1994-2003	anhydrase	substance[101]	new[101]	_	_
11-6	2004-2005	(	_	_	_	_
11-7	2006-2008	CA	abstract	new	coref	14-1
11-8	2009-2010	)	_	_	_	_
11-9	2011-2013	is	_	_	_	_
11-10	2014-2015	a	substance[104]	giv[104]	coref	16-33[164_104]
11-11	2016-2025	naturally	substance[104]	giv[104]	_	_
11-12	2026-2035	occurring	substance[104]	giv[104]	_	_
11-13	2036-2040	zinc	substance|substance[104]	giv|giv[104]	coref	12-7
11-14	2041-2054	metalloenzyme	substance[104]	giv[104]	_	_
11-15	2055-2059	that	substance[104]	giv[104]	_	_
11-16	2060-2071	efficiently	substance[104]	giv[104]	_	_
11-17	2072-2075	and	substance[104]	giv[104]	_	_
11-18	2076-2086	reversibly	substance[104]	giv[104]	_	_
11-19	2087-2096	catalyzes	substance[104]	giv[104]	_	_
11-20	2097-2100	the	substance[104]|abstract[105]	giv[104]|new[105]	ana	12-1[0_105]
11-21	2101-2110	hydration	substance[104]|abstract[105]	giv[104]|new[105]	_	_
11-22	2111-2113	of	substance[104]|abstract[105]	giv[104]|new[105]	_	_
11-23	2114-2117	CO2	substance[104]|abstract[105]|substance	giv[104]|new[105]|new	coref	13-20[128_0]
11-24	2118-2122	into	substance[104]	giv[104]	_	_
11-25	2123-2131	hydrogen	substance[104]|substance|substance[108]	giv[104]|giv|new[108]	_	_
11-26	2132-2141	carbonate	substance[104]|substance[108]	giv[104]|new[108]	_	_
11-27	2142-2143	(	_	_	_	_
11-28	2144-2149	HCO3−	_	_	_	_
11-29	2150-2151	)	_	_	_	_
11-30	2152-2153	.	_	_	_	_

#Text=Its high activity originates from its zinc ( Zn(II ) ) containing active site , in which three histidine imidazole moieties coordinate a Zn(II)-ion leaving a vacant space for the association of a water molecule .
12-1	2154-2157	Its	abstract|abstract[110]	giv|new[110]	ana|coref	12-6|16-38[166_110]
12-2	2158-2162	high	abstract[110]	new[110]	_	_
12-3	2163-2171	activity	abstract[110]	new[110]	_	_
12-4	2172-2182	originates	_	_	_	_
12-5	2183-2187	from	_	_	_	_
12-6	2188-2191	its	abstract|place[114]	giv|new[114]	_	_
12-7	2192-2196	zinc	substance|place[114]	giv|new[114]	_	_
12-8	2197-2198	(	place[114]	new[114]	_	_
12-9	2199-2204	Zn(II	abstract|place[114]	new|new[114]	coref	13-1
12-10	2205-2206	)	place[114]	new[114]	_	_
12-11	2207-2208	)	place[114]	new[114]	_	_
12-12	2209-2219	containing	place[114]	new[114]	_	_
12-13	2220-2226	active	place[114]	new[114]	_	_
12-14	2227-2231	site	place[114]	new[114]	_	_
12-15	2232-2233	,	place[114]	new[114]	_	_
12-16	2234-2236	in	place[114]	new[114]	_	_
12-17	2237-2242	which	place[114]	new[114]	_	_
12-18	2243-2248	three	place[114]|abstract[117]	new[114]|new[117]	_	_
12-19	2249-2258	histidine	place[114]|animal|abstract[117]	new[114]|new|new[117]	_	_
12-20	2259-2268	imidazole	place[114]|substance|abstract[117]	new[114]|new|new[117]	_	_
12-21	2269-2277	moieties	place[114]|abstract[117]	new[114]|new[117]	_	_
12-22	2278-2288	coordinate	place[114]	new[114]	_	_
12-23	2289-2290	a	place[114]|substance[118]	new[114]|new[118]	_	_
12-24	2291-2301	Zn(II)-ion	place[114]|substance[118]	new[114]|new[118]	_	_
12-25	2302-2309	leaving	place[114]|substance[118]	new[114]|new[118]	_	_
12-26	2310-2311	a	place[114]|substance[118]|place[119]	new[114]|new[118]|new[119]	_	_
12-27	2312-2318	vacant	place[114]|substance[118]|place[119]	new[114]|new[118]|new[119]	_	_
12-28	2319-2324	space	place[114]|substance[118]|place[119]	new[114]|new[118]|new[119]	_	_
12-29	2325-2328	for	place[114]|substance[118]|place[119]	new[114]|new[118]|new[119]	_	_
12-30	2329-2332	the	place[114]|substance[118]|place[119]|abstract[120]	new[114]|new[118]|new[119]|new[120]	_	_
12-31	2333-2344	association	place[114]|substance[118]|place[119]|abstract[120]	new[114]|new[118]|new[119]|new[120]	_	_
12-32	2345-2347	of	place[114]|substance[118]|place[119]|abstract[120]	new[114]|new[118]|new[119]|new[120]	_	_
12-33	2348-2349	a	place[114]|substance[118]|place[119]|abstract[120]|object[122]	new[114]|new[118]|new[119]|new[120]|new[122]	_	_
12-34	2350-2355	water	place[114]|substance[118]|place[119]|abstract[120]|substance|object[122]	new[114]|new[118]|new[119]|new[120]|new|new[122]	coref	13-7[125_0]
12-35	2356-2364	molecule	place[114]|substance[118]|place[119]|abstract[120]|object[122]	new[114]|new[118]|new[119]|new[120]|new[122]	_	_
12-36	2365-2366	.	_	_	_	_

#Text=Zn(II ) lowers the pKa of the bound water and forms a highly nucleophilic hydroxide species which reacts with CO2 , bound in close proximity , to yield HCO3− .
13-1	2367-2372	Zn(II	abstract	giv	_	_
13-2	2373-2374	)	_	_	_	_
13-3	2375-2381	lowers	_	_	_	_
13-4	2382-2385	the	abstract[124]	giv[124]	_	_
13-5	2386-2389	pKa	abstract[124]	giv[124]	_	_
13-6	2390-2392	of	abstract[124]	giv[124]	_	_
13-7	2393-2396	the	abstract[124]|substance[125]	giv[124]|giv[125]	_	_
13-8	2397-2402	bound	abstract[124]|substance[125]	giv[124]|giv[125]	_	_
13-9	2403-2408	water	abstract[124]|substance[125]	giv[124]|giv[125]	_	_
13-10	2409-2412	and	_	_	_	_
13-11	2413-2418	forms	_	_	_	_
13-12	2419-2420	a	substance[127]	new[127]	_	_
13-13	2421-2427	highly	substance[127]	new[127]	_	_
13-14	2428-2440	nucleophilic	substance[127]	new[127]	_	_
13-15	2441-2450	hydroxide	animal|substance[127]	new|new[127]	_	_
13-16	2451-2458	species	substance[127]	new[127]	_	_
13-17	2459-2464	which	substance[127]	new[127]	_	_
13-18	2465-2471	reacts	substance[127]	new[127]	_	_
13-19	2472-2476	with	substance[127]	new[127]	_	_
13-20	2477-2480	CO2	substance[127]|substance[128]	new[127]|giv[128]	coref	15-13[0_128]
13-21	2481-2482	,	substance[127]|substance[128]	new[127]|giv[128]	_	_
13-22	2483-2488	bound	substance[127]|substance[128]	new[127]|giv[128]	_	_
13-23	2489-2491	in	substance[127]|substance[128]	new[127]|giv[128]	_	_
13-24	2492-2497	close	substance[127]|substance[128]|abstract[129]	new[127]|giv[128]|new[129]	_	_
13-25	2498-2507	proximity	substance[127]|substance[128]|abstract[129]	new[127]|giv[128]|new[129]	_	_
13-26	2508-2509	,	_	_	_	_
13-27	2510-2512	to	_	_	_	_
13-28	2513-2518	yield	_	_	_	_
13-29	2519-2524	HCO3−	_	_	_	_
13-30	2525-2526	.	_	_	_	_

#Text=CA isoforms have been extensively studied due to their clinical importance as drug targets and artificial lungs , and their great potential as catalysts in carbon capture systems .
14-1	2527-2529	CA	abstract|substance[131]	giv|new[131]	ana	14-9[0_131]
14-2	2530-2538	isoforms	substance[131]	new[131]	_	_
14-3	2539-2543	have	_	_	_	_
14-4	2544-2548	been	_	_	_	_
14-5	2549-2560	extensively	_	_	_	_
14-6	2561-2568	studied	_	_	_	_
14-7	2569-2572	due	_	_	_	_
14-8	2573-2575	to	_	_	_	_
14-9	2576-2581	their	substance|abstract[133]	giv|new[133]	ana	14-20
14-10	2582-2590	clinical	abstract[133]	new[133]	_	_
14-11	2591-2601	importance	abstract[133]	new[133]	_	_
14-12	2602-2604	as	abstract[133]	new[133]	_	_
14-13	2605-2609	drug	abstract[133]|substance|abstract[135]	new[133]|new|new[135]	_	_
14-14	2610-2617	targets	abstract[133]|abstract[135]	new[133]|new[135]	_	_
14-15	2618-2621	and	abstract[133]	new[133]	_	_
14-16	2622-2632	artificial	abstract[133]|object[136]	new[133]|new[136]	_	_
14-17	2633-2638	lungs	abstract[133]|object[136]	new[133]|new[136]	_	_
14-18	2639-2640	,	_	_	_	_
14-19	2641-2644	and	_	_	_	_
14-20	2645-2650	their	substance|abstract[138]	giv|new[138]	_	_
14-21	2651-2656	great	abstract[138]	new[138]	_	_
14-22	2657-2666	potential	abstract[138]	new[138]	_	_
14-23	2667-2669	as	abstract[138]	new[138]	_	_
14-24	2670-2679	catalysts	abstract[138]|substance[139]	new[138]|new[139]	_	_
14-25	2680-2682	in	abstract[138]|substance[139]	new[138]|new[139]	_	_
14-26	2683-2689	carbon	abstract[138]|substance[139]|substance|event[141]|abstract[142]	new[138]|new[139]|new|new[141]|giv[142]	_	_
14-27	2690-2697	capture	abstract[138]|substance[139]|event[141]|abstract[142]	new[138]|new[139]|new[141]|giv[142]	_	_
14-28	2698-2705	systems	abstract[138]|substance[139]|abstract[142]	new[138]|new[139]|giv[142]	_	_
14-29	2706-2707	.	_	_	_	_

#Text=Especially the latter application drove our interest , as the emission of CO2 and the associated anthropogenic climate change steadily proceeds and new approaches for the absorption of CO2 become increasingly urgent .
15-1	2708-2718	Especially	abstract[143]	giv[143]	_	_
15-2	2719-2722	the	abstract[143]	giv[143]	_	_
15-3	2723-2729	latter	abstract[143]	giv[143]	_	_
15-4	2730-2741	application	abstract[143]	giv[143]	_	_
15-5	2742-2747	drove	_	_	_	_
15-6	2748-2751	our	person|abstract[145]	acc|new[145]	ana	16-6
15-7	2752-2760	interest	abstract[145]	new[145]	_	_
15-8	2761-2762	,	_	_	_	_
15-9	2763-2765	as	_	_	_	_
15-10	2766-2769	the	abstract[146]	new[146]	_	_
15-11	2770-2778	emission	abstract[146]	new[146]	_	_
15-12	2779-2781	of	abstract[146]	new[146]	_	_
15-13	2782-2785	CO2	abstract[146]|substance	new[146]|giv	coref	15-29
15-14	2786-2789	and	_	_	_	_
15-15	2790-2793	the	abstract[149]	new[149]	_	_
15-16	2794-2804	associated	abstract[149]	new[149]	_	_
15-17	2805-2818	anthropogenic	abstract[149]	new[149]	_	_
15-18	2819-2826	climate	abstract|abstract[149]	new|new[149]	_	_
15-19	2827-2833	change	abstract[149]	new[149]	_	_
15-20	2834-2842	steadily	_	_	_	_
15-21	2843-2851	proceeds	_	_	_	_
15-22	2852-2855	and	_	_	_	_
15-23	2856-2859	new	abstract[150]	giv[150]	_	_
15-24	2860-2870	approaches	abstract[150]	giv[150]	_	_
15-25	2871-2874	for	abstract[150]	giv[150]	_	_
15-26	2875-2878	the	abstract[150]|event[151]	giv[150]|new[151]	coref	16-21[158_151]
15-27	2879-2889	absorption	abstract[150]|event[151]	giv[150]|new[151]	_	_
15-28	2890-2892	of	abstract[150]|event[151]	giv[150]|new[151]	_	_
15-29	2893-2896	CO2	abstract[150]|event[151]|substance	giv[150]|new[151]|giv	_	_
15-30	2897-2903	become	_	_	_	_
15-31	2904-2916	increasingly	_	_	_	_
15-32	2917-2923	urgent	_	_	_	_
15-33	2924-2925	.	_	_	_	_

#Text=In order to further increase our understanding of the design of Pep-Au-NPs , and to present a new approach for the absorption CO2 , we herein describe the design and synthesis of the first Pep-Au-NP metalloenzyme mimicking carbonic anhydrase activity .
16-1	2926-2928	In	_	_	_	_
16-2	2929-2934	order	_	_	_	_
16-3	2935-2937	to	_	_	_	_
16-4	2938-2945	further	_	_	_	_
16-5	2946-2954	increase	_	_	_	_
16-6	2955-2958	our	person|abstract[154]	giv|new[154]	ana	16-25
16-7	2959-2972	understanding	abstract[154]	new[154]	_	_
16-8	2973-2975	of	abstract[154]	new[154]	_	_
16-9	2976-2979	the	abstract[154]|abstract[155]	new[154]|new[155]	coref	16-28[160_155]
16-10	2980-2986	design	abstract[154]|abstract[155]	new[154]|new[155]	_	_
16-11	2987-2989	of	abstract[154]|abstract[155]	new[154]|new[155]	_	_
16-12	2990-3000	Pep-Au-NPs	abstract[154]|abstract[155]|abstract	new[154]|new[155]|giv	_	_
16-13	3001-3002	,	_	_	_	_
16-14	3003-3006	and	_	_	_	_
16-15	3007-3009	to	_	_	_	_
16-16	3010-3017	present	_	_	_	_
16-17	3018-3019	a	abstract[157]	new[157]	_	_
16-18	3020-3023	new	abstract[157]	new[157]	_	_
16-19	3024-3032	approach	abstract[157]	new[157]	_	_
16-20	3033-3036	for	abstract[157]	new[157]	_	_
16-21	3037-3040	the	abstract[157]|event[158]	new[157]|giv[158]	_	_
16-22	3041-3051	absorption	abstract[157]|event[158]	new[157]|giv[158]	_	_
16-23	3052-3055	CO2	abstract[157]|event[158]	new[157]|giv[158]	_	_
16-24	3056-3057	,	_	_	_	_
16-25	3058-3060	we	person	giv	_	_
16-26	3061-3067	herein	_	_	_	_
16-27	3068-3076	describe	_	_	_	_
16-28	3077-3080	the	abstract[160]|abstract[161]	giv[160]|giv[161]	_	_
16-29	3081-3087	design	abstract[160]|abstract[161]	giv[160]|giv[161]	_	_
16-30	3088-3091	and	abstract[161]	giv[161]	_	_
16-31	3092-3101	synthesis	abstract[161]|event[162]	giv[161]|giv[162]	_	_
16-32	3102-3104	of	abstract[161]|event[162]	giv[161]|giv[162]	_	_
16-33	3105-3108	the	abstract[161]|event[162]|substance[164]	giv[161]|giv[162]|giv[164]	coref	16-39[0_164]
16-34	3109-3114	first	abstract[161]|event[162]|substance[164]	giv[161]|giv[162]|giv[164]	_	_
16-35	3115-3124	Pep-Au-NP	abstract[161]|event[162]|abstract|substance[164]	giv[161]|giv[162]|new|giv[164]	_	_
16-36	3125-3138	metalloenzyme	abstract[161]|event[162]|substance[164]	giv[161]|giv[162]|giv[164]	_	_
16-37	3139-3148	mimicking	abstract[161]|event[162]|substance[164]	giv[161]|giv[162]|giv[164]	_	_
16-38	3149-3157	carbonic	abstract[161]|event[162]|substance[164]|abstract[166]	giv[161]|giv[162]|giv[164]|giv[166]	_	_
16-39	3158-3167	anhydrase	abstract[161]|event[162]|substance[164]|substance|abstract[166]	giv[161]|giv[162]|giv[164]|giv|giv[166]	_	_
16-40	3168-3176	activity	abstract[161]|event[162]|substance[164]|abstract[166]	giv[161]|giv[162]|giv[164]|giv[166]	_	_
16-41	3177-3178	.	_	_	_	_
